Mathieu Epardaud is an immunologist specializing in immunotherapies and vaccinology, currently serving as a Senior Scientist at INRAE since 2008. They co-founded LoValTech in January 2022, where they work as a Scientific Consultant, focusing on preclinical studies and intranasal delivery systems for vaccine applications. Mathieu's previous experience includes postdoctoral research fellowships at Harvard Medical School and Dana-Farber Cancer Institute, and a scientist role at the Institut de Génétique Moléculaire de Montpellier from 2009 to 2014. They completed their education at Université François Rabelais de Tours, graduating in 2017.
Location
Tours, France
This person is not in any offices